These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27289376)

  • 21. Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma.
    Lipworth B; Stewart KE; Chan R
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):274-275. PubMed ID: 35613664
    [No Abstract]   [Full Text] [Related]  

  • 22. Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium.
    Hamelmann E
    Biomed Res Int; 2018; 2018():7473690. PubMed ID: 30474042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging therapeutic options for the treatment of patients with symptomatic asthma.
    McIvor RA
    Ann Allergy Asthma Immunol; 2015 Oct; 115(4):265-271.e5. PubMed ID: 26254973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
    Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asthma exacerbations and worsenings in patients aged 1-75 years with add-on tiotropium treatment.
    Mark FitzGerald J; Hamelmann E; Kerstjens HAM; Buhl R
    NPJ Prim Care Respir Med; 2020 Aug; 30(1):38. PubMed ID: 32868782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review.
    Calzetta L; Coppola A; Ritondo BL; Matino M; Chetta A; Rogliani P
    Int J Chron Obstruct Pulmon Dis; 2021; 16():257-279. PubMed ID: 33603353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tiotropium in the management of paediatric and adolescent asthma: Systematic review.
    Sunther M; Marchon K; Gupta A
    Paediatr Respir Rev; 2021 Jun; 38():58-62. PubMed ID: 33243704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD.
    Kistemaker LE; Oenema TA; Meurs H; Gosens R
    Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscarinic receptor antagonists: effects on pulmonary function.
    Buels KS; Fryer AD
    Handb Exp Pharmacol; 2012; (208):317-41. PubMed ID: 22222705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.
    Kardos P; Worsley S; Singh D; Román-Rodríguez M; Newby DE; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2885-2895. PubMed ID: 27932872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affirmation of the adoration of the vagi and role of tiotropium in asthmatic patients.
    Gelb AF; Nadel JA
    J Allergy Clin Immunol; 2016 Oct; 138(4):1011-1013. PubMed ID: 27527265
    [No Abstract]   [Full Text] [Related]  

  • 32. Tiotropium may improve asthma symptoms and lung function in asthmatic patients with irreversible airway obstruction: the real-life data.
    Abadoglu O; Berk S
    Clin Respir J; 2016 Jul; 10(4):421-7. PubMed ID: 25335652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives.
    Chari VM; McIvor RA
    Can Respir J; 2018; 2018():3464960. PubMed ID: 29670674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the pharmacokinetics of M
    Matera MG; Rinaldi B; Berardo C; Rinaldi M; Cazzola M
    Expert Opin Drug Metab Toxicol; 2020 Feb; 16(2):143-148. PubMed ID: 31958237
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
    Jones PW
    Ther Adv Respir Dis; 2015 Jun; 9(3):84-96. PubMed ID: 25801643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.
    Trudo F; Kern DM; Davis JR; Tunceli O; Zhou S; Graham EL; Strange C; Williams SA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2055-66. PubMed ID: 26451101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Umeclidinium for the treatment of uncontrolled asthma.
    Ferrando M; Bagnasco D; Braido F; Baiardini I; Passalacqua G; Puggioni F; Varricchi G; Canonica GW
    Expert Opin Investig Drugs; 2017 Jun; 26(6):761-766. PubMed ID: 28406326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticholinergics for treatment of asthma.
    Quirce S; Domínguez-Ortega J; Barranco P
    J Investig Allergol Clin Immunol; 2015; 25(2):84-93; quiz 94-5. PubMed ID: 25997301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mode of action of anticholinergics in asthma.
    Gosens R; Gross N
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30115613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.